Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F L J Visseren

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 5, 2011
Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemiaF L J Visseren
European Heart Journal|March 1, 2008
Vascular consequences of metabolic syndrome in early lifeF L J Visseren
Nederlands Tijdschrift Voor Geneeskunde|May 11, 2017
[Syncope; suspect pulmonary embolism, especially in the elderly]W Opstelten, F L J Visseren
Nederlands Tijdschrift Voor Geneeskunde|February 24, 2006
[Sensory disturbances caused by multivitamin preparations]W Spiering, F L J Visseren
European Journal of Clinical Investigation|November 17, 2009
Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL-profilesJ Westerink, F L J Visseren
Seminars in Vascular Medicine|June 17, 2004
Oral anticoagulant therapy in patients with peripheral artery diseaseF L J Visseren, B C Eikelboom
Nederlands Tijdschrift Voor Geneeskunde|December 5, 2008
[Doubts regarding the existence and clinical relevance of 'new' risk determinants of cardiovascular disease are unfounded]F L J Visseren, Y van der Graaf
Nederlands Tijdschrift Voor Geneeskunde|February 9, 2008
[Infection-induced vascular disease: little evidence according to the Koch's postulates]F L J Visseren, W Spiering, I M Hoepelman
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|August 12, 2011
Mechanisms linking obesity to hypertensionJ A N Dorresteijn, F L J Visseren, W Spiering
Nederlands Tijdschrift Voor Geneeskunde|July 2, 2020
[A fasting lipid profile is not a necessity in majority of cases]L Louter, F L J Visseren, J E Roeters van Lennep
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 5, 2011
Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemiaF L J Visseren
European Heart Journal|March 1, 2008
Vascular consequences of metabolic syndrome in early lifeF L J Visseren
Nederlands Tijdschrift Voor Geneeskunde|May 11, 2017
[Syncope; suspect pulmonary embolism, especially in the elderly]W Opstelten, F L J Visseren
Nederlands Tijdschrift Voor Geneeskunde|February 24, 2006
[Sensory disturbances caused by multivitamin preparations]W Spiering, F L J Visseren
European Journal of Clinical Investigation|November 17, 2009
Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL-profilesJ Westerink, F L J Visseren
Seminars in Vascular Medicine|June 17, 2004
Oral anticoagulant therapy in patients with peripheral artery diseaseF L J Visseren, B C Eikelboom
Nederlands Tijdschrift Voor Geneeskunde|December 5, 2008
[Doubts regarding the existence and clinical relevance of 'new' risk determinants of cardiovascular disease are unfounded]F L J Visseren, Y van der Graaf
Nederlands Tijdschrift Voor Geneeskunde|February 9, 2008
[Infection-induced vascular disease: little evidence according to the Koch's postulates]F L J Visseren, W Spiering, I M Hoepelman
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|August 12, 2011
Mechanisms linking obesity to hypertensionJ A N Dorresteijn, F L J Visseren, W Spiering
Nederlands Tijdschrift Voor Geneeskunde|July 2, 2020
[A fasting lipid profile is not a necessity in majority of cases]L Louter, F L J Visseren, J E Roeters van Lennep
Pageof 9